A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

Abstract Background Novel, pragmatic, patient-centered strategies are needed to ensure fit-for-purpose patient-reported outcomes (PRO) instruments in clinical trial research for rare diseases such as myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (...

Full description

Bibliographic Details
Main Authors: Jill A. Bell, Aaron Galaznik, Farrah Pompilus, Sara Strzok, Rafael Bejar, Fatima Scipione, Robert J. Fram, Douglas V. Faller, Stefan Cano, Patrick Marquis
Format: Article
Language:English
Published: SpringerOpen 2019-06-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Patient-reported outcomes
Quality of life
Myelodysplastic syndromes
Acute myeloid leukemia
Chronic myelomonocytic leukemia
Online Access:http://link.springer.com/article/10.1186/s41687-019-0123-4

Internet

http://link.springer.com/article/10.1186/s41687-019-0123-4

Similar Items